Imetelstat Achieves Meaningful and Durable Transfusion Independence in High Transfusion–Burden Patients With Lower-Risk MDS
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Imetelstat Achieves Meaningful and Durable Transfusion Independence in High Transfusion–Burden Patients With Lower-Risk Myelodysplastic Syndromes in a Phase II Study
J. Clin. Oncol 2020 Oct 27;[EPub Ahead of Print], DP Steensma, P Fenaux, K Van Eygen, A Raza, V Santini, U Germing, P Font, M Diez-Campelo, S Thepot, E Vellenga, MM Patnaik, JH Jang, H Varsos, J Bussolari, E Rose, L Sherman, L Sun, Y Wan, S Dougherty, F Huang, F Feller, A Rizo, U PlatzbeckerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.